MBK Tape Solutions

MBK Tape Solutions is a U. S. -based company specializing in medical-grade precision converting, focusing on engineered materials for biosensors, transdermal patches, and medical wearables. Founded in 1971 and headquartered in the United States, MBK Tape Solutions specializes in producing medical-grade adhesive solutions.

In December 2021, the company was acquired by Boyd Corporation, which bolstered its capabilities in medical materials sciences. The CEO, Jeff Kaminski, leads the company, which has undergone significant strategic shifts to enhance its market position. MBK Tape Solutions, now a division of Boyd, provides a variety of engineered materials primarily for applications in biosensors, transdermal patches, and medical wearables. Their product range includes advanced medical adhesive tapes and wearable solutions designed to improve patient care outside clinical environments, serving clients in North America and Europe with a focus on reliable stick-to-skin performance.

The revenue of MBK Tape Solutions is primarily generated through B2B transactions with clients in the medical manufacturing sector. The company engages in long-term contracts with healthcare and pharmaceutical organizations, supplying customized adhesive solutions and multi-layer assemblies. Their flagship products, including high-performance medical adhesive tapes, leverage expertise in material science and clean room environments to meet industry standards. MBK Tape Solutions is poised for future growth by designing new products tailored for advanced medical applications, capitalizing on recent acquisitions to strengthen its market presence.

The company plans to expand into new geographical regions, specifically targeting additional markets in North America and Europe by 2024. The acquisition by Boyd Corporation in December 2021 facilitates investment in innovative medical materials, enhancing their offerings in wound care and transdermal patches.